# Genitourinary Agents: Benign Prostatic Hyperplasia

**LENGTH OF AUTHORIZATIONS**: 365 Days

**PRIOR AUTHORIZATION CRITERIA:**

1. Is there any reason the patient cannot be changed to a medication not requiring prior approval?

    Acceptable reasons include:

    - Allergy to medications not requiring prior approval

    - Contraindications to or drug interaction with medications not requiring prior approval

    - History of unacceptable/toxic side effects to medications not requiring prior approval

2. Patient must have a therapeutic failure to no less than a **30-day** trial on at least **two** medications that are preferred.

**ADDITIONAL CRITERIA FOR APPROVAL OF TADALAFIL (CIALIS):**

Patient must have diagnosis of benign prostatic hyperplasia and have a therapeutic failure to no less than a 30-day trial on at least one alpha-1 adrenergic blocker and a 90-day trial of finasteride.

## Benign Prostatic Hyperplasia

| Genitourinary Agents: Benign Prostatic Hyperplasia  |                         |
|-----------------------------------------------------|-------------------------|
| PREFERRED                                           | NON-PREFERRED           |
| Alfuzosin                                           | Cardura XL              |
| Doxazosin                                           | Dutasteride/Tamsulosin  |
| Dutasteride                                         | Silodosin               |
| Finasteride                                         |                         |
| Prazosin                                            |                         |
| Tadalafil PA 2.5, 5mg                               |                         |
| Tamsulosin                                          |                         |
| Terazosin                                           |                         |

**Link to Criteria:** [Genitourinary Agents: Benign Prostatic Hyperplasia](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=66)
